The Addition of Urinary Urokinase-Type Plasminogen Activator to Urinary Nuclear Matrix Protein 22 and Cytology Improves the Detection of Bladder Cancer
β Scribed by SHARIAT, SHAHROKH F.; CASELLA, ROBERTO; MONOSKI, MARA A.; SULSER, TULLIO; GASSER, THOMAS C.; LERNER, SETH P.
- Book ID
- 122070627
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2003
- Tongue
- English
- Weight
- 229 KB
- Volume
- 170
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The authors found previously that plasma levels of urokinase-type plasminogen activator (upa) and its receptor (upar) were elevated in patients with bladder carcinoma and were associated with features of biologically aggressive disease. in the current study, they tested the hypothesi
## Urokinase -type plasminogen activator (u-PA) is thought to be implicated in cancer invasion and metastasis. The aim of this study was to determine whether the u-PA content of cancer tissue is a prognostic factor in bladder cancer. Tissue samples from 46 patients with bladder cancer were assesse